Wednesday 29 May 2019

• 12:30 - Molecular targeting enables effective theranostic approaches in thrombotic and inflammatory diseases, including unstable atherosclerotic plaques, cardiac ischemia/reperfusion and cancer
  Professor Karlheinz Peter (Baker Heart and Diabetes Institute, Melbourne, Australia)
  Division of Cardiovascular Medicine